Cargando…

Selective Pharmacological Targeting of a DEAD Box RNA Helicase

RNA helicases represent a large family of proteins implicated in many biological processes including ribosome biogenesis, splicing, translation and mRNA degradation. However, these proteins have little substrate specificity, making inhibition of selected helicases a challenging problem. The prototyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindqvist, Lisa, Oberer, Monika, Reibarkh, Mikhail, Cencic, Regina, Bordeleau, Marie-Eve, Vogt, Emily, Marintchev, Assen, Tanaka, Junichi, Fagotto, Francois, Altmann, Michael, Wagner, Gerhard, Pelletier, Jerry
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216682/
https://www.ncbi.nlm.nih.gov/pubmed/18270573
http://dx.doi.org/10.1371/journal.pone.0001583
_version_ 1782149172919533568
author Lindqvist, Lisa
Oberer, Monika
Reibarkh, Mikhail
Cencic, Regina
Bordeleau, Marie-Eve
Vogt, Emily
Marintchev, Assen
Tanaka, Junichi
Fagotto, Francois
Altmann, Michael
Wagner, Gerhard
Pelletier, Jerry
author_facet Lindqvist, Lisa
Oberer, Monika
Reibarkh, Mikhail
Cencic, Regina
Bordeleau, Marie-Eve
Vogt, Emily
Marintchev, Assen
Tanaka, Junichi
Fagotto, Francois
Altmann, Michael
Wagner, Gerhard
Pelletier, Jerry
author_sort Lindqvist, Lisa
collection PubMed
description RNA helicases represent a large family of proteins implicated in many biological processes including ribosome biogenesis, splicing, translation and mRNA degradation. However, these proteins have little substrate specificity, making inhibition of selected helicases a challenging problem. The prototypical DEAD box RNA helicase, eIF4A, works in conjunction with other translation factors to prepare mRNA templates for ribosome recruitment during translation initiation. Herein, we provide insight into the selectivity of a small molecule inhibitor of eIF4A, hippuristanol. This coral-derived natural product binds to amino acids adjacent to, and overlapping with, two conserved motifs present in the carboxy-terminal domain of eIF4A. Mutagenesis of amino acids within this region allowed us to alter the hippuristanol-sensitivity of eIF4A and undertake structure/function studies. Our results provide an understanding into how selective targeting of RNA helicases for pharmacological intervention can be achieved.
format Text
id pubmed-2216682
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-22166822008-02-13 Selective Pharmacological Targeting of a DEAD Box RNA Helicase Lindqvist, Lisa Oberer, Monika Reibarkh, Mikhail Cencic, Regina Bordeleau, Marie-Eve Vogt, Emily Marintchev, Assen Tanaka, Junichi Fagotto, Francois Altmann, Michael Wagner, Gerhard Pelletier, Jerry PLoS One Research Article RNA helicases represent a large family of proteins implicated in many biological processes including ribosome biogenesis, splicing, translation and mRNA degradation. However, these proteins have little substrate specificity, making inhibition of selected helicases a challenging problem. The prototypical DEAD box RNA helicase, eIF4A, works in conjunction with other translation factors to prepare mRNA templates for ribosome recruitment during translation initiation. Herein, we provide insight into the selectivity of a small molecule inhibitor of eIF4A, hippuristanol. This coral-derived natural product binds to amino acids adjacent to, and overlapping with, two conserved motifs present in the carboxy-terminal domain of eIF4A. Mutagenesis of amino acids within this region allowed us to alter the hippuristanol-sensitivity of eIF4A and undertake structure/function studies. Our results provide an understanding into how selective targeting of RNA helicases for pharmacological intervention can be achieved. Public Library of Science 2008-02-13 /pmc/articles/PMC2216682/ /pubmed/18270573 http://dx.doi.org/10.1371/journal.pone.0001583 Text en Lindqvist et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lindqvist, Lisa
Oberer, Monika
Reibarkh, Mikhail
Cencic, Regina
Bordeleau, Marie-Eve
Vogt, Emily
Marintchev, Assen
Tanaka, Junichi
Fagotto, Francois
Altmann, Michael
Wagner, Gerhard
Pelletier, Jerry
Selective Pharmacological Targeting of a DEAD Box RNA Helicase
title Selective Pharmacological Targeting of a DEAD Box RNA Helicase
title_full Selective Pharmacological Targeting of a DEAD Box RNA Helicase
title_fullStr Selective Pharmacological Targeting of a DEAD Box RNA Helicase
title_full_unstemmed Selective Pharmacological Targeting of a DEAD Box RNA Helicase
title_short Selective Pharmacological Targeting of a DEAD Box RNA Helicase
title_sort selective pharmacological targeting of a dead box rna helicase
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216682/
https://www.ncbi.nlm.nih.gov/pubmed/18270573
http://dx.doi.org/10.1371/journal.pone.0001583
work_keys_str_mv AT lindqvistlisa selectivepharmacologicaltargetingofadeadboxrnahelicase
AT oberermonika selectivepharmacologicaltargetingofadeadboxrnahelicase
AT reibarkhmikhail selectivepharmacologicaltargetingofadeadboxrnahelicase
AT cencicregina selectivepharmacologicaltargetingofadeadboxrnahelicase
AT bordeleaumarieeve selectivepharmacologicaltargetingofadeadboxrnahelicase
AT vogtemily selectivepharmacologicaltargetingofadeadboxrnahelicase
AT marintchevassen selectivepharmacologicaltargetingofadeadboxrnahelicase
AT tanakajunichi selectivepharmacologicaltargetingofadeadboxrnahelicase
AT fagottofrancois selectivepharmacologicaltargetingofadeadboxrnahelicase
AT altmannmichael selectivepharmacologicaltargetingofadeadboxrnahelicase
AT wagnergerhard selectivepharmacologicaltargetingofadeadboxrnahelicase
AT pelletierjerry selectivepharmacologicaltargetingofadeadboxrnahelicase